Gene Delivery Systems

Gene therapy has undergone a remarkable development in the last 20 years. Particularly important advances have been made in the improvement of gene transfer and expression technology, with current efforts focusing on the design of safer and long-term gene expression vectors as well as systems possessing cell-type specificity for transgene delivery and regulat‐ ability of its expression by small molecules. The foreign genetic material can be administered in vivo, ex vivo or in vitro depending on the nature of a disease. A successful gene therapy system must perform several functions. In all cases, the therapeutic gene must first be delivered across the cell membrane, which is a significant barrier. Once delivered inside the cell, the therapeutic gene may exist episomally or be integrated into the host genome depending on the nature of the gene transfer vector. Moreover, an important issue is the replication and segregation of the therapeutic gene during cell division in order to maintain long-lasting gene expression. These specifications will be discussed for each gene delivery system along the chapter.

[1]  N. Brunetti‐Pierri Helper-dependent adenoviral vectors for gene therapy , 2014 .

[2]  I. Alferiev,et al.  Adenoviral vector tethering to metal surfaces via hydrolyzable cross-linkers for the modulation of vector release and transduction. , 2013, Biomaterials.

[3]  Jun Chang,et al.  Viral vectors for vaccine applications , 2013, Clinical and experimental vaccine research.

[4]  Pavel Zrazhevskiy,et al.  Quantum dots as a platform for nanoparticle drug delivery vehicle design. , 2013, Advanced drug delivery reviews.

[5]  D. Agrawal,et al.  Clinical and Translational Challenges in Gene Therapy of Cardiovascular Diseases , 2013 .

[6]  M. Nakanishi,et al.  Development of Sendai Virus Vectors and their Potential Applications in Gene Therapy and Regenerative Medicine , 2012, Current gene therapy.

[7]  U. Krishnan,et al.  Translational siRNA therapeutics using liposomal carriers: prospects & challenges. , 2012, Current gene therapy.

[8]  O. Tolmachov Self-entanglement of long linear DNA vectors using transient non-B-DNA attachment points: a new concept for improvement of non-viral therapeutic gene delivery. , 2012, Medical hypotheses.

[9]  Y. Meir,et al.  Transposon-based vector systems for gene therapy clinical trials: challenges and considerations. , 2011, Chang Gung medical journal.

[10]  Rinti Banerjee,et al.  Nanostructured self assembled lipid materials for drug delivery and tissue engineering. , 2011, Therapeutic delivery.

[11]  Christian Plank,et al.  Magnetically enhanced nucleic acid delivery. Ten years of magnetofection—Progress and prospects , 2011, Advanced Drug Delivery Reviews.

[12]  O. Mykhaylyk,et al.  Magselectofection: an integrated method of nanomagnetic separation and genetic modification of target cells. , 2011, Blood.

[13]  R. Compans,et al.  Induction of Influenza-Specific Mucosal Immunity by an Attenuated Recombinant Sendai Virus , 2011, PloS one.

[14]  H. Nakauchi,et al.  Development of Defective and Persistent Sendai Virus Vector , 2010, The Journal of Biological Chemistry.

[15]  Murali M. Yallapu,et al.  PEG-Functionalized Magnetic Nanoparticles for Drug Delivery and Magnetic Resonance Imaging Applications , 2010, Pharmaceutical Research.

[16]  Stefan Thalhammer,et al.  Boosting oncolytic adenovirus potency with magnetic nanoparticles and magnetic force. , 2010, Molecular pharmaceutics.

[17]  Cui Tang,et al.  Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. , 2010, Biomaterials.

[18]  T. Daniels,et al.  A versatile targeting system with lentiviral vectors bearing the biotin‐adaptor peptide , 2009, The journal of gene medicine.

[19]  Robert J Levy,et al.  Magnetically responsive biodegradable nanoparticles enhance adenoviral gene transfer in cultured smooth muscle and endothelial cells. , 2009, Molecular pharmaceutics.

[20]  Peter Wipf,et al.  Nanoparticles in cellular drug delivery. , 2009, Bioorganic & medicinal chemistry.

[21]  Ning Wang,et al.  Mechanochemical delivery and dynamic tracking of fluorescent quantum dots in the cytoplasm and nucleus of living cells. , 2009, Nano letters.

[22]  Sangjin Park,et al.  Carbon nanosyringe array as a platform for intracellular delivery. , 2009, Nano letters.

[23]  J. Glorioso,et al.  Therapeutic Gene Transfer with Replication-Defective Herpes Simplex Viral Vectors , 2008 .

[24]  A. Schambach,et al.  Retroviral Vectors for Cell and Gene Therapy , 2008 .

[25]  K. Airenne,et al.  Targeting and purification of metabolically biotinylated baculovirus. , 2008, Human gene therapy.

[26]  Paul H Lerou,et al.  Generation of human-induced pluripotent stem cells , 2008, Nature Protocols.

[27]  M. Barry,et al.  Current advances and future challenges in Adenoviral vector biology and targeting. , 2007, Current gene therapy.

[28]  K. Longmuir,et al.  Effective Targeting of Liposomes to Liver and Hepatocytes In Vivo by Incorporation of a Plasmodium Amino Acid Sequence , 2006, Pharmaceutical Research.

[29]  G. Mufti,et al.  Conjugation of Lentivirus to Paramagnetic Particles via Nonviral Proteins Allows Efficient Concentration and Infection of Primary Acute Myeloid Leukemia Cells , 2005, Journal of Virology.

[30]  Ajay Kumar Gupta,et al.  Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. , 2005, Biomaterials.

[31]  T. Brill,et al.  Advances in magnetofection—magnetically guided nucleic acid delivery , 2005 .

[32]  A. Panet,et al.  Synchronized Infection of Cell Cultures by Magnetically Controlled Virus , 2005, Journal of Virology.

[33]  M. Imperiale,et al.  Biology of adenovirus and its use as a vector for gene therapy. , 2004, Human gene therapy.

[34]  Varpu Marjomäki,et al.  Enhanced gene delivery by avidin-displaying baculovirus. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[35]  S. Kochanek,et al.  Adenoviral vectors for gene transfer and therapy , 2004, The journal of gene medicine.

[36]  B. Carter,et al.  Adeno-associated Virus and AAV Vectors for Gene Delivery , 2003 .

[37]  R. Crystal,et al.  Adenovirus Vectors for Gene Therapy , 2003 .

[38]  U. Greber,et al.  Adenovirus endocytosis , 2003, The journal of gene medicine.

[39]  M. Sandri,et al.  Electrotransfer in differentiated myotubes: a novel, efficient procedure for functional gene transfer. , 2003, Experimental cell research.

[40]  Wei‐Yin Sun,et al.  Electrochemically driven clathration/declathration of ferrocene and its derivatives by a nanometer-sized coordination cage. , 2002, Journal of the American Chemical Society.

[41]  Jon Dobson,et al.  Improved method of recombinant AAV2 delivery for systemic targeted gene therapy. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[42]  P. Quax,et al.  Exploiting the Natural Diversity in Adenovirus Tropism for Therapy and Prevention of Disease , 2002, Journal of Virology.

[43]  J. Roy-Chowdhury,et al.  Evolution of adenoviruses as gene therapy vectors. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[44]  B. Thimmapaya,et al.  High-efficiency adenovirus-mediated in vivo gene transfer into neonatal and adult rodent skeletal muscle , 2002, Journal of Neuroscience Methods.

[45]  In-Hoo Kim,et al.  Lifetime correction of genetic deficiency in mice with a single injection of helper-dependent adenoviral vector , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[46]  A. Shiotani,et al.  Skeletal muscle regeneration after insulin-like growth factor I gene transfer by recombinant Sendai virus vector , 2001, Gene Therapy.

[47]  E. Wolf,et al.  Muscle-Specific Overexpression of the Adenovirus Primary Receptor CAR Overcomes Low Efficiency of Gene Transfer to Mature Skeletal Muscle , 2001, Journal of Virology.

[48]  H. Herweijer,et al.  Time course of gene expression after plasmid DNA gene transfer to the liver , 2001, The journal of gene medicine.

[49]  I. Kovesdi,et al.  The role of receptors in the maturation-dependent adenoviral transduction of myofibers , 2001, Gene Therapy.

[50]  F. Farzaneh,et al.  Streptavidin paramagnetic particles provide a choice of three affinity-based capture and magnetic concentration strategies for retroviral vectors. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[51]  A. Theofilopoulos,et al.  Immunotherapeutic gene transfer into muscle. , 2001, Trends in immunology.

[52]  M. Uchino,et al.  Efficient repetitive gene delivery to skeletal muscle using recombinant adenovirus vector containing the Coxsackievirus and adenovirus receptor cDNA , 2001, Gene Therapy.

[53]  W. Russell,et al.  Update on adenovirus and its vectors. , 2000, The Journal of general virology.

[54]  P. Hallauer,et al.  Skeletal muscle gene transfer: regeneration-associated deregulation of fast troponin I fiber type specificity. , 2000, American journal of physiology. Cell physiology.

[55]  R. Samulski,et al.  The use of adeno-associated virus to circumvent the maturation-dependent viral transduction of muscle fibers. , 2000, Human gene therapy.

[56]  A. P. Alivisatos,et al.  A new nonhydrolytic single-precursor approach to surfactant-capped nanocrystals of transition metal oxides , 1999 .

[57]  A. Amalfitano,et al.  Next-generation adenoviral vectors: new and improved , 1999, Gene Therapy.

[58]  E. Hoffman,et al.  Polylysine modification of adenoviral fiber protein enhances muscle cell transduction. , 1999, Human gene therapy.

[59]  G. Pari,et al.  Expression of the primary coxsackie and adenovirus receptor is downregulated during skeletal muscle maturation and limits the efficacy of adenovirus-mediated gene delivery to muscle cells. , 1999, Human gene therapy.

[60]  T. Matsunaga,et al.  Biomagnetic nanoparticle formation and application , 1998 .

[61]  J. Glorioso,et al.  Implications of maturation for viral gene delivery to skeletal muscle , 1998, Neuromuscular Disorders.

[62]  D. Brough,et al.  Adenoviral vectors for gene transfer. , 1997, Current opinion in biotechnology.

[63]  Simon C Watkins,et al.  Gene transfer to muscle using herpes simplex virus-based vectors , 1997, Neuromuscular Disorders.

[64]  Simon C Watkins,et al.  The basal lamina is a physical barrier to herpes simplex virus-mediated gene delivery to mature muscle fibers , 1996, Journal of virology.

[65]  A. Bangham Surrogate cells or Trojan horses. The discovery of liposomes. , 1995, BioEssays : news and reviews in molecular, cellular and developmental biology.

[66]  Xiang Gao,et al.  Cationic liposome-mediated gene transfer. , 1995, Gene therapy.

[67]  Hanns Lochmüller,et al.  Differential short-term transduction efficiency of adult versus newborn mouse tissues by adenoviral recombinants. , 1995, Experimental and molecular pathology.

[68]  G. Acsadi,et al.  A differential efficiency of adenovirus-mediated in vivo gene transfer into skeletal muscle cells of different maturity. , 1994, Human molecular genetics.

[69]  G. Prince,et al.  The molecular basis of adenovirus pathogenesis. , 1994, Infectious agents and disease.

[70]  P. Tonali,et al.  Retroviral vector-mediated gene transfer into human primary myogenic cells leads to expression in muscle fibers in vivo. , 1993, Human gene therapy.

[71]  G. Acsadi,et al.  Persistence of plasmid DNA and expression in rat brain cells in vivo , 1992, Experimental Neurology.

[72]  R. Feynman There’s plenty of room at the bottom , 1992, Journal of Microelectromechanical Systems.

[73]  G. Repetto,et al.  Direct gene transfer into nonhuman primate myofibers in vivo. , 1992, Human gene therapy.

[74]  A. Miller,et al.  Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection , 1990, Molecular and cellular biology.

[75]  G. Acsadi,et al.  Direct gene transfer into mouse muscle in vivo. , 1990, Science.

[76]  P. Yurchenco,et al.  Assembly of Basement Membranes a , 1990, Annals of the New York Academy of Sciences.

[77]  A. Gabizon,et al.  Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[78]  N. Muzyczka,et al.  Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[79]  K. Kandori,et al.  Preparation and characterization of monodisperse magnetite sols in microemulsion , 1983 .

[80]  G. Rubin,et al.  Transposition of cloned P elements into Drosophila germ line chromosomes. , 1982, Science.

[81]  K. Widder,et al.  Magnetic Microspheres: A Model System for Site Specific Drug Delivery in Vivo 1 , 1978, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[82]  F. Graham,et al.  Characteristics of a human cell line transformed by DNA from human adenovirus type 5. , 1977, The Journal of general virology.

[83]  R. Huebner,et al.  Isolation of a Cytopathogenic Agent from Human Adenoids Undergoing Spontaneous Degeneration in Tissue Culture , 1953, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[84]  O. Mykhaylyk,et al.  Effects of nanoparticle coatings on the activity of oncolytic adenovirus-magnetic nanoparticle complexes. , 2012, Biomaterials.

[85]  T. D. Gruijl,et al.  Chapter six--Adenovirus-based immunotherapy of cancer: promises to keep. , 2012 .

[86]  Christian Plank,et al.  Generation of magnetic nonviral gene transfer agents and magnetofection in vitro , 2007, Nature Protocols.

[87]  Huang Liu-yu,et al.  Transposon-Based Strategies For Microbial Functional Genomics , 2006 .

[88]  S. Kochanek,et al.  Comparison of high-capacity and first-generation adenoviral vector gene delivery to murine muscle in utero , 2005, Gene Therapy.

[89]  A. Józkowicz,et al.  Helper-dependent adenoviral vectors in experimental gene therapy. , 2005, Acta biochimica Polonica.

[90]  T. Daly Overview of adeno-associated viral vectors. , 2004, Methods in molecular biology.

[91]  J. Glorioso,et al.  Delivery using herpes simplex virus: an overview. , 2004, Methods in molecular biology.

[92]  N. Somia Gene transfer by retroviral vectors: an overview. , 2004, Methods in molecular biology.

[93]  M. Rudnicki,et al.  Cellular and molecular regulation of muscle regeneration. , 2004, Physiological reviews.

[94]  N. Somia Gene Transfer by Retroviral Vectors , 2004 .

[95]  J Henke,et al.  Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo , 2002, Gene Therapy.

[96]  R. Proulx,et al.  A combination of poloxamers increases gene expression of plasmid DNA in skeletal muscle , 2000, Gene Therapy.